Cyr SL - Search Results

1

Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.

Cyr SL, Jones T, Stoica-Popescu I, Brewer A, Chabot S, Lussier M, Burt D, Ward BJ. Cyr SL, et al. Vaccine. 2007 Jul 20;25(29):5378-89. doi: 10.1016/j.vaccine.2007.05.004. Epub 2007 May 24. Vaccine. 2007. PMID: 17561317

2

Protollin: a novel adjuvant for intranasal vaccines.

Jones T, Cyr S, Allard F, Bellerose N, Lowell GH, Burt DS. Jones T, et al. Vaccine. 2004 Sep 9;22(27-28):3691-7. doi: 10.1016/j.vaccine.2004.03.035. Vaccine. 2004. PMID: 15315848

3

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

Chabot S, Brewer A, Lowell G, Plante M, Cyr S, Burt DS, Ward BJ. Chabot S, et al. Vaccine. 2005 Feb 3;23(11):1374-83. doi: 10.1016/j.vaccine.2004.09.010. Vaccine. 2005. PMID: 15661386

4

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

Jones T, Allard F, Cyr SL, Tran SP, Plante M, Gauthier J, Bellerose N, Lowell GH, Burt DS. Jones T, et al. Among authors: cyr sl. Vaccine. 2003 Sep 8;21(25-26):3706-12. doi: 10.1016/s0264-410x(03)00387-6. Vaccine. 2003. PMID: 12922101

5

Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.

Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS. Jones T, et al. Among authors: cyr sl. Vaccine. 2006 Mar 6;24(10):1625-32. doi: 10.1016/j.vaccine.2005.09.052. Epub 2005 Oct 7. Vaccine. 2006. PMID: 16243411

6

C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.

Cyr SL, Jones T, Stoica-Popescu I, Burt D, Ward BJ. Cyr SL, et al. Vaccine. 2007 Apr 20;25(16):3228-32. doi: 10.1016/j.vaccine.2007.01.037. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17374422

7

TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.

Cyr SL, Angers I, Guillot L, Stoica-Popescu I, Lussier M, Qureshi S, Burt DS, Ward BJ. Cyr SL, et al. Vaccine. 2009 Jan 14;27(3):421-30. doi: 10.1016/j.vaccine.2008.10.073. Epub 2008 Nov 14. Vaccine. 2009. PMID: 19013492

8

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces.

Chabot SM, Chernin TS, Shawi M, Wagner J, Farrant S, Burt DS, Cyr S, Neutra MR. Chabot SM, et al. Vaccine. 2007 Jul 20;25(29):5348-58. doi: 10.1016/j.vaccine.2007.05.029. Epub 2007 Jun 6. Vaccine. 2007. PMID: 17582662

9

Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

Huang Y, Cyr SL, Burt DS, Anderson R. Huang Y, et al. Among authors: cyr sl. J Clin Virol. 2009 Apr;44(4):287-91. doi: 10.1016/j.jcv.2009.01.009. Epub 2009 Feb 23. J Clin Virol. 2009. PMID: 19233722

10

Mucosal immunology - 11th International Congress.

Cyr S. Cyr S. IDrugs. 2002 Aug;5(8):753-6. IDrugs. 2002. PMID: 14686363 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters